The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(6-chloro-1-(4-chlorophenyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2(9H)-yl)(3-(morpholinomethyl)phenyl)methanone ID: ALA4462587
PubChem CID: 155529054
Max Phase: Preclinical
Molecular Formula: C29H27Cl2N3O2
Molecular Weight: 520.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1cccc(CN2CCOCC2)c1)N1CCc2c([nH]c3ccc(Cl)cc23)C1c1ccc(Cl)cc1
Standard InChI: InChI=1S/C29H27Cl2N3O2/c30-22-6-4-20(5-7-22)28-27-24(25-17-23(31)8-9-26(25)32-27)10-11-34(28)29(35)21-3-1-2-19(16-21)18-33-12-14-36-15-13-33/h1-9,16-17,28,32H,10-15,18H2
Standard InChI Key: QZOONIXDQDCTSX-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 41 0 0 0 0 0 0 0 0999 V2000
17.0135 -26.2745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7147 -25.8586 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7029 -25.0429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9899 -24.6430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0250 -27.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3211 -27.5068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3314 -28.3232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0449 -28.7233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7495 -28.3011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7357 -27.4861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3051 -25.8790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2904 -25.0668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5372 -26.1440 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0478 -25.4956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5135 -24.8326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1720 -24.0999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3651 -24.0290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9009 -24.6968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2450 -25.4269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4277 -26.2580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4384 -27.0751 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0186 -23.2889 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.1300 -25.8401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8392 -26.2408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5411 -25.8237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5308 -25.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8128 -24.6066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1139 -25.0261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2538 -26.2233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2641 -27.0405 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.5623 -27.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5706 -28.2680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2816 -28.6715 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.9859 -28.2553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9792 -27.4355 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0567 -29.5404 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
12 4 1 0
11 1 1 0
1 2 1 0
2 3 1 0
3 4 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
1 5 1 0
11 12 2 0
12 15 1 0
14 13 1 0
13 11 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
2 20 1 0
20 21 2 0
17 22 1 0
20 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
25 29 1 0
29 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
8 36 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 520.46Molecular Weight (Monoisotopic): 519.1480AlogP: 6.09#Rotatable Bonds: 4Polar Surface Area: 48.57Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 6.02CX LogP: 5.77CX LogD: 5.75Aromatic Rings: 4Heavy Atoms: 36QED Weighted: 0.35Np Likeness Score: -1.26
References 1. Tikhmyanova N, Paparoidamis N, Romero-Masters J, Feng X, Mohammed FS, Reddy PAN, Kenney SC, Lieberman PM, Salvino JM.. (2019) Development of a novel inducer for EBV lytic therapy., 29 (16): [PMID:31255485 ] [10.1016/j.bmcl.2019.06.034 ]